(BCSF) Bain Capital Specialty - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 859m USD | Total Return: -0.3% in 12m
Avg Turnover: 4.08M
EPS Trend: -73.3%
Qual. Beats: 0
Rev. Trend: -61.7%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Bain Capital Specialty Finance, Inc. (BCSF) is a Business Development Company (BDC) focused on providing direct lending solutions to middle-market enterprises. The fund prioritizes senior secured debt, including first-lien, second-lien, and unitranche structures, targeting companies with annual EBITDA ranging from $10 million to $150 million.
As a BDC, the company is legally required to distribute at least 90% of its taxable income to shareholders annually to maintain its tax-advantaged status. This business model benefits from the structural shift of middle-market financing away from traditional commercial banks toward private credit providers who can offer more flexible, tailored capital solutions. For a deeper look at the underlying fundamentals of this BDC, explore the data available on ValueRay.
- Floating rate loan portfolio benefits from sustained elevated interest rate environments
- Credit quality stability depends on middle-market company EBITDA growth and leverage
- Net investment income coverage of quarterly dividends drives investor total returns
- Strategic co-investment platform with Bain Capital Credit enhances proprietary deal flow
- Regulatory leverage limits and debt-to-equity ratios constrain future portfolio expansion potential
| Net Income: 73.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.83 > 1.0 |
| NWC/Revenue: -248.0% < 20% (prev 37.83%; Δ -285.8% < -1%) |
| CFO/TA 0.03 > 3% & CFO 86.6m > Net Income 73.6m |
| Net Debt (1.42b) to EBITDA (97.5m): 14.61 < 3 |
| Current Ratio: 0.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.9m) vs 12m ago 0.30% < -2% |
| Gross Margin: 61.16% > 18% (prev 0.64%; Δ 6.05k% > 0.5%) |
| Asset Turnover: 7.50% > 50% (prev 7.84%; Δ -0.34% > 0%) |
| Interest Coverage Ratio: 1.19 > 6 (EBITDA TTM 97.5m / Interest Expense TTM 81.9m) |
| A: -0.19 (Total Current Assets 112.3m - Total Current Liabilities 600.0m) / Total Assets 2.60b |
| B: -0.03 (Retained Earnings -67.6m / Total Assets 2.60b) |
| C: 0.04 (EBIT TTM 97.5m / Avg Total Assets 2.62b) |
| D: -0.04 (Book Value of Equity -67.6m / Total Liabilities 1.51b) |
| Altman-Z'' = -1.11 = CCC |
As of May 24, 2026, the stock is trading at USD 13.21 with a total of 314,093 shares traded.
Over the past week, the price has changed by -1.12%,
over one month by +0.69%,
over three months by +6.59% and
over the past year by -0.27%.
Bain Capital Specialty has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold BCSF.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13.7 | 3.5% |
P/E Forward = 10.1112
P/S = 3.1509
P/B = 0.7777
P/EG = 1.0474
Revenue TTM = 196.7m USD
EBIT TTM = 97.5m USD
EBITDA TTM = 97.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 600.0m USD (from shortTermDebt, last fiscal year)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (calculated: Debt 1.45b - CCE 30.6m)
Enterprise Value = 2.28b USD (858.9m + Debt 1.45b - CCE 30.6m)
Interest Coverage Ratio = 1.19 (Ebit TTM 97.5m / Interest Expense TTM 81.9m)
EV/FCF = 25.17x (Enterprise Value 2.28b / FCF TTM 90.7m)
FCF Yield = 3.97% (FCF TTM 90.7m / Enterprise Value 2.28b)
FCF Margin = 46.13% (FCF TTM 90.7m / Revenue TTM 196.7m)
Net Margin = 37.42% (Net Income TTM 73.6m / Revenue TTM 196.7m)
Gross Margin = 61.16% ((Revenue TTM 196.7m - Cost of Revenue TTM 76.4m) / Revenue TTM)
Gross Margin QoQ = 72.55% (prev 61.60%)
Tobins Q-Ratio = 0.88 (Enterprise Value 2.28b / Total Assets 2.60b)
Interest Expense / Debt = 5.63% (Interest Expense 81.9m / Debt 1.45b)
Taxrate = 21.09% (906k / 4.30m)
NOPAT = 76.9m (EBIT 97.5m * (1 - 21.09%))
Current Ratio = 0.19 (Total Current Assets 112.3m / Total Current Liabilities 600.0m)
Debt / Equity = 1.33 (Debt 1.45b / totalStockholderEquity, last quarter 1.09b)
Debt / EBITDA = 14.61 (Net Debt 1.42b / EBITDA 97.5m)
Debt / FCF = 15.70 (Net Debt 1.42b / FCF TTM 90.7m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 73.6m / Total Assets 2.60b)
RoE = 6.20% (Net Income TTM 73.6m / Total Stockholder Equity 1.19b)
RoCE = 4.87% (EBIT 97.5m / Capital Employed (Total Assets 2.60b - Current Liab 600.0m))
RoIC = 2.47% (NOPAT 76.9m / Invested Capital 3.12b)
WACC = 5.97% (E(858.9m)/V(2.31b) * Re(8.55%) + D(1.45b)/V(2.31b) * Rd(5.63%) * (1-Tc(0.21)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.60 | Cagr: 0.21%
[DCF] Terminal Value 73.10% ; FCFF base≈100.0m ; Y1≈87.7m ; Y5≈70.9m
[DCF] Fair Price = N/A (negative equity: EV 1.14b - Net Debt 1.42b = -286.5m; debt exceeds intrinsic value)
EPS Correlation: -73.26 | EPS CAGR: -6.56% | SUE: -0.39 | # QB: 0
Revenue Correlation: -61.69 | Revenue CAGR: -4.01% | SUE: -0.60 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.42 | Chg30d=+2.42% | Revisions=+20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.43 | Chg30d=+7.50% | Revisions=+20% | Analysts=3
EPS current Year (2026-12-31): EPS=1.70 | Chg30d=+5.50% | Revisions=+33% | GrowthEPS=-9.8% | GrowthRev=-6.0%
EPS next Year (2027-12-31): EPS=1.48 | Chg30d=+2.06% | Revisions=+33% | GrowthEPS=-12.5% | GrowthRev=-5.1%
[Analyst] Revisions Ratio: +33%